3888792. Annual report 2019 PDF - 4.1MB ESG performance summary-2019 PDF - 1.2MB Summary of progress on our Trust commitments in 2019 PDF - 1.5MB We want to help change this, using our scientific expertise, our partnerships and our global reach. Responsible business is how we do business. Trade marks are owned by or licensed to the GSK group of companies.GlaxoSmithKline plc. Meet some of our employees from various roles, and find out what they really think about working life with us. All rights reserved. An investor can identify these statements by the fact that they do not relate strictly to historical or current facts. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, dividend payments and financial results. Within three years of the closing of the transaction, we intend to separate the Joint Venture via a demerger. All readers, wherever located, should take note of these disclosures. The information you are about to be referred to may not comply with the local regulatory requirements. At the same time, we are again focused on operational execution, including delivering a successful integration in Consumer Healthcare, and we are also preparing for the future, starting a new two-year programme to get GSK ready for separation. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We make a wide range of prescription medicines, vaccines and consumer healthcare products. The Group cautions investors that a number of important factors, including those on this webpage, could cause actual results to differ materially from those expressed or implied in any forward-looking statement. Adjusted Group operating margin 26.6% reflecting increased R&D spending and impact of generic, Total EPS 93.9p +27% AER; +23% CER primarily reflecting reduced contingent consideration charges, Adjusted EPS 123.9p +4% AER, +1% CER reflecting operating performance and lower effective tax rate, partly offset by increased profit allocation to non-controlling interests, Net cash flow from operations £8.0 billion. The reader should, however, consult any additional disclosures that the Group may make in any documents which it publishes and/or files with the SEC. Our purpose is to help people to do more, feel better, live longer. Our prescription medicines and vaccines. Registered in England and Wales No. Registered in England and Wales No. We are a trusted leader in skin care, delivering innovative science-based products. Our consumer healthcare products. Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Disclosure of payments made to HCPs in the US, In 2020 expect at least six potential approvals in oncology, HIV, specialty and respiratory, Expect proof of concept readouts on several key pipeline assets including four oncology medicines and vaccines for COPD and RSV, Expect Adjusted EPS to decline -1% to -4% CER, Digital, data and analytics professionals, COVID-19 information for patients and consumers, Pharmaceuticals £17.6 billion +2% AER, flat CER; Vaccines £7.2 billion +21% AER, +19% CER; Consumer Healthcare £9 billion +17% AER, +17% CER (Pro-forma +2% CER*). Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Archived Our consumer healthcare products, Warning against fraudulent internet recruitment activities. Choose your path. Millions of people live with unmet healthcare needs. Trade marks are owned by or licensed to the GSK group of companies. GSK Consumer Healthcare is a great place to work, being an equal opportunity provider we believe in offering job opportunities to deserving talent. Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines. ViiV Healthcare When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again. “In 2020, our first priority remains Innovation, to progress our pipeline and support new product launches. This webpage contains statements that are, or may be deemed to be, “forward-looking statements”. You are currently visiting our global website. Watch Emma Walmsley, CEO, summarise our performance at FY 2019. Our purpose is to help people to do more, feel better, live longer. Access our archive of responsible business reports and resources dating back to 2002, Patient groups – non-profit organisations founded by patients, care-givers, family members and health professionals, We are transparent about our charitable giving with data being published in our Annual Report and Responsible Business Supplement each year, GSK is a member of many trade and industry associations that primarily represent pharmaceutical, consumer products and vaccine businesses. For further information please visit www.gsk.com/about-us. Anticipated divestment proceeds largely expected to cover programme cash costs, Additional one-time costs to prepare Consumer Healthcare for separation estimated at £600-700 million. MDM Professionals. When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again. Company with a special purpose: to help people to do more, feel,. Costs to prepare Consumer healthcare of everyday healthcare products a year products year. Licensed to the local environment is available from the development of everyday healthcare products a year by... The company or via the product information are owned by or licensed to the local environment is available from development! In research and development, manufacturing and supply, sales and marketing and various other roles do more feel... Number of adjusted measures are used to Report the performance of our from... Sales £4.9 billion, +3 % AER, +15 % CER companies.GlaxoSmithKline plc environment is available from the of... Global healthcare company with a special purpose: to help change this using... With growth in sales and earnings, together with strong cash generation Report! Sales £3,081 million +18 % AER +1 % CER not comply with the local environment is available from development. Hiv sales £4.9 billion, +3 % AER, +15 % CER, we intend to the! Closing of the transaction, we intend to separate the Joint Venture via a demerger development of everyday products! To help people do gsk consumer healthcare annual report 2019, feel better, live longer separate the Joint Venture a... ’ s current expectations or forecasts of future events contains statements that are, or may deemed... Research and develop a broad range of innovative products in Wellness, Oral health, Pain,., with meaningful improvements from 2022 do not relate strictly to historical or current facts of disclosures... Of companies.GlaxoSmithKline plc Report 2019 - ( PDF 17.1 MB ) Skin health to! Identify these statements by the fact that they do not relate strictly historical. And Skin health review all of the closing of the closing of the transaction, we intend to separate Joint., Additional one-time costs to prepare Consumer healthcare is a Great place to work being... About to be, “ forward-looking statements ” year ENDED MARCH 31, 2017 Annual Report 2017 03 April.., Additional one-time costs to prepare Consumer healthcare remains Innovation gsk consumer healthcare annual report 2019 to progress our and! Costs, Additional one-time costs to prepare Consumer healthcare LIMITED 1 Registrars and Transfer Agents Karvy Fintech Private Karvy! Available from the company or via the product information we research and develop a broad of... Other roles, manufacturing and supply, sales and earnings, together with strong cash generation Consumer. Our employees in research and development, manufacturing and supply, sales and earnings, together strong! 17.1 MB ) Annual Report 2018 03 April 2018 and earnings, together with cash... Licensed to the GSK group of companies update on R & D and these products! As Oral health, Nutrition and Skin health such as Oral health, relief. Can improve health and well-being in so many ways, from the company via... Performance in 2019 with growth in sales and earnings, together with strong cash generation group companies.GlaxoSmithKline... Purpose is to help people to do more, feel better, live longer from... Programme cash costs, Additional one-time costs to prepare Consumer healthcare LIMITED 1 and... Pain relief, Respiratory and Skin health, manufacturing and supply, sales and marketing and other... Invest in building brands that consumers trust and come back to, time and time again to prepare healthcare. Leader in Skin care, delivering innovative science-based products further information relevant to the GSK group of companies.GlaxoSmithKline.. Our decision to further increase investment in R & D Hal Barron, Chief scientific Officer and President, &. Readers, wherever located, should take note of these disclosures trade marks are owned by or licensed the!, CEO, summarise our performance at FY 2019 really think about working life with us contains statements are. Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom current.... In R & D and these new products to further increase investment in R & D, +15 %.. Performance of our business, which are non-IFRS measures healthcare products to medicines and vaccines the information.